InhibrxInc Return on Sales vs Price to Sales Ratio Analysis
INBX Stock | USD 34.32 0.13 0.38% |
Trend analysis of InhibrxInc balance sheet accounts such as Other Liabilities of 120.2 K or Net Tangible Assets of 70.1 M provides information on InhibrxInc's total assets, liabilities, and equity, which is the actual value of InhibrxInc to its prevalent stockholders. By breaking down trends over time using InhibrxInc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
InhibrxInc |
About InhibrxInc Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of InhibrxInc at a specified time, usually calculated after every quarter, six months, or one year. InhibrxInc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of InhibrxInc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which InhibrxInc currently owns. An asset can also be divided into two categories, current and non-current.
InhibrxInc Balance Sheet Chart
InhibrxInc Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how InhibrxInc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, InhibrxInc's Cash And Short Term Investments are fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 323.3 M in 2024, whereas Other Liabilities is likely to drop slightly above 120.2 K in 2024. Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on InhibrxInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of InhibrxInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents InhibrxInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of InhibrxInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from InhibrxInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InhibrxInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.At this time, InhibrxInc's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 210 M in 2024, whereas Tax Provision is likely to drop 2,565 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 83.7M | 131.3M | 219.8M | 230.8M | Cost Of Revenue | 2.7M | 2.8M | 1.2M | 1.1M |
InhibrxInc fundamental ratios Correlations
Click cells to compare fundamentals
InhibrxInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InhibrxInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 4.8M | 13.4M | 9.6M | 17.2M | 43.3M | 45.5M | |
Total Current Liabilities | 20.6M | 31.4M | 22.5M | 27.6M | 56.3M | 59.1M | |
Other Liab | 363K | 2.9M | 917K | 110K | 126.5K | 120.2K | |
Net Tangible Assets | (93.6M) | 75.5M | 52.4M | 58.1M | 66.8M | 70.1M | |
Retained Earnings | (69.3M) | (145.4M) | (227.1M) | (372.4M) | (613.7M) | (583.0M) | |
Accounts Payable | 3.1M | 13.5M | 9.1M | 8.3M | 11.0M | 7.2M | |
Other Current Assets | 376K | 132.2M | 7.8M | 6.6M | 16.7M | 22.7M | |
Total Current Assets | 15.6M | 132.2M | 139.1M | 280.5M | 295.4M | 310.1M | |
Property Plant Equipment | 10.7M | 11.3M | 9.5M | 2.5M | 2.9M | 2.7M | |
Total Assets | 26.5M | 143.7M | 150.5M | 290.9M | 307.9M | 323.3M | |
Short Long Term Debt Total | 41.7M | 37.5M | 70.5M | 202.1M | 210.1M | 220.6M | |
Total Stockholder Equity | (93.6M) | 75.5M | 52.4M | 58.1M | 43.5M | 45.7M | |
Property Plant And Equipment Net | 10.7M | 11.3M | 9.5M | 7.2M | 9.4M | 8.2M | |
Current Deferred Revenue | 7.9M | 3.1M | 2.0M | 166K | 149.4K | 141.9K | |
Net Debt | 30.2M | (91.2M) | (60.8M) | (71.8M) | (67.8M) | (64.4M) | |
Cash | 11.5M | 128.7M | 131.3M | 273.9M | 277.9M | 291.8M | |
Non Current Assets Total | 10.9M | 11.6M | 11.3M | 10.4M | 12.5M | 9.9M | |
Long Term Debt | 30.4M | 29.2M | 70.5M | 202.1M | 207.0M | 217.3M | |
Cash And Short Term Investments | 11.5M | 128.7M | 131.3M | 273.9M | 277.9M | 291.8M | |
Net Receivables | 438K | 615K | 878K | 257K | 778K | 497.4K | |
Common Stock Shares Outstanding | 36.6M | 25.3M | 38.0M | 40.1M | 47.1M | 38.2M | |
Liabilities And Stockholders Equity | 26.5M | 143.7M | 150.5M | 290.9M | 307.9M | 323.3M | |
Non Current Liabilities Total | 99.5M | 36.9M | 75.6M | 205.2M | 208.1M | 111.2M | |
Capital Lease Obligations | 7.8M | 8.2M | 6.7M | 5.0M | 3.2M | 4.9M | |
Inventory | 3.2M | (129.3M) | (878K) | (257K) | (231.3K) | (242.9K) | |
Other Stockholder Equity | (24.3M) | 220.8M | 279.5M | 430.4M | 657.2M | 690.1M | |
Total Liab | 120.1M | 68.3M | 98.1M | 232.8M | 264.4M | 140.0M | |
Net Invested Capital | (59.6M) | 104.7M | 70.5M | 260.1M | 250.5M | 263.0M | |
Property Plant And Equipment Gross | 10.7M | 11.3M | 3.2M | 2.5M | 16.1M | 16.9M | |
Accumulated Other Comprehensive Income | (1.7M) | (59.5M) | (143.7M) | (150.5M) | (135.4M) | (128.6M) | |
Net Working Capital | (5.0M) | 100.8M | 116.7M | 252.9M | 239.0M | 251.0M | |
Short Term Debt | 4.7M | 1.5M | 1.7M | 1.9M | 2.1M | 2.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.